Skip common site navigation and headers
United States Environmental Protection Agency
Endocrine Disruptor Research Initiative
Contact Us | Print Version Search: NCER Advanced Search
Begin Hierarchical Links EPA Home > Table2.NCI >  62951-03 Environmental and Genetic Determinants of Breast Cancer End Hierarchical Links End Hierarchical Links

 

EDRI Federal Project Inventory:
62951-03 Environmental and Genetic Determinants of Breast Cancer



  1. Sponsor Organization: NIH/NCI

  2. Project Title: 62951-03 ENVIRONMENTAL AND GENETIC DETERMINANTS OF BREAST CANCER

  3. Project Focus: HUMAN HEALTH EFFECTS

  4. Description: Preliminary research conducted by our group has found a powerful association between female breast cancer andbody burden of DDE, the principal metabolite of DDT. This association is stronger (RR equals approximately 4) thanthat between breast cancer and obesity (RR less than 1.5) or delayed child-bearing (RR less than 2). Lower, butelevated, risks were found with PCBs. These exposures are preventable. We will investigate breast cancer risk amongwomen in the New York metropolitan area, including minorities, with respect to environmental factors, carcinogenmetabolizing enzymes, and oncogenes. Levels of organochlorines (DDE and PCB) in blood serum will be comparedbetween breast cancer cases and two control groups. The relationship of breast cancer to genetic polymorphisms incarcinogen metabolizing genes (CYP1A1, CYP1A2, CYP2E1, GST) will be determined. Interactions of genotype withenvironmental exposures and carcinogen metabolizing genes will be investigated with respect to risk of breast cancer. Expression of p53, c-myc and erbB-2 in relation to organochlorine exposure and carcinogen-metabolizing genotype willbe assessed. Estrogen receptor and epidermal growth factor receptor levels will be determined in an effort to determinerelationships between breast cancer risk and environmental exposures, cytochrome P450 metabolism and oncogeneexpression. In order to verify the validity of blood serum levels as an indicator of body burden, organochlorine levels inmammary or upper abdominal adipose will be compared with levels in blood serum for a subset of each case and controlgroup. A case-control study has been designed to compare 210 patient cases of invasive cancer, including 140 (66)minority women, with 2 control groups. The control groups comprise 210 patients that required biopsy for non-hyperplastic benign breast disease and 210 women hospitalized for elective abdominal surgery (noncancer). Cases andcontrols will be frequency-matched on age and race. Residence status in New York City, Long Island, and New Jerseywill be a variable in the analysis. Patients will be drawn from over 1000 breast biopsies seen annually in the MountSinai Breast Service. In addition to the effect variables needed to assess the hypotheses, data will include potentialconfounders for both breast cancer and organochlorine environmental exposures. Statistical analyses will be designed tomodel cancer risk associated with environmental exposures and their interactions with genetic and biologic markers.

  5. References:

  6. Category: MEASUREMENTS

  7. Subcategory: EXPOSURE AND RISK MODELS

  8. Keywords for Experimental System/Species: HUMAN, FIELD STUDY

  9. Keywords for Experimental Endpoints: CARCINOGENESIS, FEMALE, EXPOSURE MONITORING, CYTOCHROME P450

  10. Chemical Agents: PCBs, DDT

  11. Performing Institution: MOUNT SINAI SCHOOL OF MEDICINE

  12. Contact: CONTACT PERSON: ELAINE C. LEE; BUILDING 31; 11A21, NATIONAL CANCER INSTITUTE, NIH,BETHESDA, MD 20892-2590; 301- 496-5515; LEEE@OD.NCI.NIH.GOV


 

 
Begin Site Footer